CSIRO-founded Main Sequence Ventures has pocketed $194m for its second fund, which has added decarbonisation to the firm’s list of targeted technologies.

Main Sequence Ventures, the Australia-based venture capital firm founded by Commonwealth Scientific Research Organisation (CSIRO), secured A$250m ($194m) for its second fund yesterday. Limited partners include aerospace and defence manufacturer Lockheed Martin, Singaporean state-owned investment firm Temasek, superannuation fund HostPlus, venture capital firm Horizons Ventures and unspecified family offices and individual investors represented by Morgan…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.